AngioDynamics to Report Fiscal 2017 First Quarter Financial Results

ALBANY, N.Y., Sept. 21, 2016 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first quarter ended August 31, 2016, on Wednesday, October 5, 2016, before the open of the U.S. financial markets.

Management will host a conference call beginning at 8:00am E.T. on October 5 to discuss the results and to answer questions. To participate in the live call by telephone, please call 888-211-0353 and reference the Conference ID: 8618019.

A live webcast and subsequent archived replay of the conference call may be accessed via the investor relations section of the Company's website under "Events & Presentations" at investors.angiodynamics.com/events. To listen to the live webcast, please go to the website 15-minutes prior to its start to register, download and install the necessary audio software.

About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at AngioDynamics.com.

Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.

Company Contact:
AngioDynamics Inc.
Caitlin Stefanik
(518) 795-1418
[email protected]

Investor Relations Contacts:
FTI Consulting
Jim Polson
(312) 553-6730
[email protected],
Kotaro Yoshida
(212) 850-5690
[email protected]

Media Contact:
FTI Consulting
Kimberly Ha
(212) 850-5612
[email protected]